Showing results (141-150 of 223) with videos related to
Sort By:
Pageof 23
Antiviral Therapy|March 27, 2009
Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alonePhilippe Flandre, Constance Delaugerre, Jade Ghosn, et al.The Journal of Antimicrobial Chemotherapy|July 19, 2021
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trialLauriane Goldwirt, Rebecca Bauer, Geoffroy Liegeon, et al.Antimicrobial Agents and Chemotherapy|August 31, 2006
Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 yearsVincent Jullien, Saïk Urien, Déborah Hirt, et al.Plos Pathogens|June 21, 2019
Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populationsLylia Hani, Antoine Chaillon, Marie-Laure Nere, et al.Antiviral Therapy|December 19, 2002
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trialVincent Calvez, Dominique Costagliola, Diane Descamps, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 12, 2020
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)Charlotte Charpentier, Houria Ichou, Florence Damond, et al.Sexually Transmitted Infections|January 5, 2023
Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trialPaul Le Turnier, Isabelle Charreau, Audrey Gabassi, et al.Antimicrobial Agents and Chemotherapy|January 25, 2003
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Claire Lamotte, Constance Delaugerre, et al.AIDS (London, England)|March 17, 2023
Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countriesNathalie De Castro, Corine Chazallon, Carlos Brites, et al.AIDS (London, England)|November 17, 2023
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabineSylvain Chawki, Lauriane Goldwirt, Mayssam El Mouhebb, et al.Pageof 23